The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

DeepSeek’s recent claim that it can make artificial intelligence less power-hungry is just the latest reason the energy ...

DeepSeek claims it can reduce the power consumption of AI, urging the energy industry to rethink future demand estimates.

Robert F. Kennedy Jr., the nominee to lead the Department of Health and Human Services, made disputed claims before the ...

The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease ...

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

The use of weight-loss injections has become near-normalised in today's society, but one singer is joining the charge in warning against their side effects, after she claims Ozempic has left her with ...

Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.

Four of the top 10 drugs by prescription sales in 2025 will be from the new incretin class, according to the latest analysis by Evaluate. Consensus forecasts for Ozempic, Wegovy, Mounjaro and Zepbound ...

Michael Batnick said the outperformance of consumer discretionary stocks relative to consumer staples is "the most bullish ...

Investing.com -- Shares of Novo Nordisk (NYSE:NVO) fell 3.6% on Friday after the U.S. Department of Health and Human Services (HHS) announced that Ozempic and Wegovy are among 15 medications selected ...